ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing December 11, 4:00 p.m. ET:

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial (JCO: Original Report)
Charlotte Coles, et al.
Request this article

Evaluating Barriers and Opportunities to Delivering High Quality Oncology Care in a Resource Limited Setting Using a Comprehensive Needs Assessment Tool (JGO: Original Report)
Ami Bhatt, et al.
Request this article

Factors Related to Advanced Stage of Cancer Presentation in Botswana (JGO: Original Report)
Surbhi Grover, et al.
Request this article

Publishing December 10, 4:00 p.m. ET:

Implementation of Computerized Physician Order Entry for Chemotherapy: A Latin American Experience (JCO CCI: Original Report)
Fernando Valencia, et al.
Request this article

A Population Based Cohort Study Reveals Distinct Associations between Female Lung Cancer and Breast Cancer in Taiwan (JCO CCI: Original Report)
Pan-Chyr Yang, et al.
Request this article

Publishing December 7, 6:00 p.m. ET:

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle? (JCO: Rapid Communication)
Mary Hardwick, et al.
(Editorial by Kara Milliron, et al.)
Request this article
This paper will be presented at the San Antonio Breast Cancer Symposium.

Advances in Genetic Testing in Patients With Breast Cancer, High-Quality Decision Making, and Responsible Resource Allocation (JCO: Editorial)
Kara Milliron, et al.
(Accompanise Mary Hardwick, et al.)
Request this article

Publishing December 7, 4:00 p.m. ET:

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202 (JCO: Original Report)
James Dignam, et al.
Request this article

Lag Time Between Evidence and Guidelines: Can Clinical Pathways Bridge the Gap? (JOP: Original Contribution)
Sushil Beriwal, et al.
Request this article

Publishing December 6, 4:00 p.m. ET:

The Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers (JGO: Special Article)
Herbert Kim Lyerly, et al.
Request this article

Publishing December 6, 10:40 a.m. ET:

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial (JCO: Rapid Communication)
Stephen Johnston, et al.
Request this article
This paper will be presented at the San Antonio Breast Cancer Symposium. 

Publishing December 5, 4:00 p.m. ET:

Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study (JCO: Original Report)
Taofeek Owonikoko, et al.
Request this article

Unplanned Hospitalization Among Individuals With Cancer in the Year After Diagnosis (JOP: Original Contribution)
Robin L. Whitney, et al.
Request this article

Patient-Centered Medical Homes in Community Oncology Practices: Changes in Spending and Care Quality Associated With the COME HOME Experience (JOP: Original Contribution)
Teresa M. Waters, et al.
Request this article

Publishing December 4, 4:00 p.m. ET:

Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide (JCO: Original Report)
Mitchell Horwitz, et al.
Request this article

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (JCO: Original Report)
Manuel Hidalgo, et al.
Request this article

Publishing December 3, 8:00 p.m. ET:

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma (JCO: Rapid Communication)
David Scott, et al.
(Editorial by Wing Chan, et al.)
Request this article
This paper will be presented at the ASH Annual Meeting in San Diego.

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy (JCO: Original Report)
David R. Westhead, et al.
Request this article

Using Gene Expression Profiling to Move Beyond MYC/BCL2 Rearrangements in High-Grade Lymphoma (JCO: Editorial)
Wing Chan, et al.
(Accompanies David Scott, et al.)
Request this article

Publishing December 3, 4:00 p.m. ET:

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline (JCO: ASCO Special Article)
Nofisat Ismaila, et al.
Request this article

Publishing December 3, 2:30 p.m. ET:

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study (JCO: Rapid Communication)
Arnon Philip Kater, et al.
Request this article
This paper will be presented at the ASH Annual Meeting in San Diego.

Embargo Information

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.